Industry Insight
Discovery Technology
Analytical Laboratory Technology
Biopharma
Manufacturing
Delivery Systems
Ingredients, Formulation and Finishing
Bioprocessing
View our other publications with free access to extensive archives
  To print this article:
Existing subscribers please log in:
 
  USER NAME  
  PASSWORD  
   Or select

Or become a subscriber
 
 
 

Printing in Progress

The possibility of personalised treatment continues to grow, and is facilitated by the advent of 3D printing in the healthcare sector, reveals Emil Ciurczak at Doramaxx Consulting. Much-needed cures and new drugs could, therefore, finally be within our reach.

Emil Ciurczak, Doramaxx Consulting (October 2016)

Keywords: 3D printing, Quality by Design, FDA guidance, Dosage forms

    View full article    |    Back to Manufacturing section




Advair,Flovent,VentolinSymbicort,Serevent,FlonaseAstelin Rhinocort
IPTonline © 2004 The Pharmaceutical Technology Journal | Terms and Conditions | info@iptonline.com | UK Contacts |
Providing a platform of communication on new ideas, developments and innovations | UK Tel No. +44 20 77243456 | Back to top of page |